Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout – MarketBeat

eczemarelief
1 week ago
Share



Turn Therapeutics Refines GX-03 Eczema Trial After Interim Data, Eyes 2026 Readout  MarketBeat



Source link

Tags: data, eczema, Eyes, GX03, interim, MarketBeat, Readout, Refines, Therapeutics, trial, Turn
Leave a Comment
Previous Article
The Gut-Skin Axis: New Evidence Links Microbiota to Skin Disease via Inflammatory Cytokines – Dermatology Times
Next Article
Are Catalytic Converters and Polyester Clothing Impacting Eczema Rates? – HCP Live

You Might also Like

Expectations For Sanofi’s Dupixent Successor Drop On Latest Eczema Data – Citeline News & Insights
eczemarelief March 30, 2026
New Long-Term Roflumilast Cream Data for Children with Eczema – HCPLive
eczemarelief March 22, 2026
Eli Lilly and Company reports new data point to significant itch relief for pediatric eczema – Traders Union
eczemarelief March 16, 2026
Post Comment